Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway

A microsatellite, purpose-built technology for mismatch repair-deficient tumors that can solve problems such as short reading

Pending Publication Date: 2022-02-18
VLAAMS INTERUNIVERSITAIR INST VOOR BIOTECHNOLOGIE VZW +1
View PDF19 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although cheaper, these techniques utilize shorter reads and cannot be used to detect microsatellite instability on Bethesda's standard line of machines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway
  • Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway
  • Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0342] Example 1. Whole-genome sequencing of MMR-deficient endometrial tumors

[0343] To select MMR-deficient tumors for whole-genome sequencing, standard diagnostic tests were used, including immunohistochemistry for MMR proteins (MLH1, MSH2, and MSH6), assessment of microsatellite instability (MSI) with the extended Bethesda panel (Pinol et al , 2005) and profiling of the methylation profile of the MLH1 promoter. The results of immunohistochemistry and MLH1 promoter hypermethylation are shown as the first 3 rows in Table 9. The series recommended by the international MSI evaluation guidelines (i.e., the revised Bethesda series (Boland et al., 1998; Dietmaier et al., 1997)) was used at 10 markers containing mononucleotide or dinucleotide repeats (2 and 8 markers, respectively). Microsatellite instability (MSI) status was analyzed at different loci. PCR amplification was performed in two pentaplexes: multiplex A (BAT25, BAT26, D5S346, D17S250, D2S123) and multiplex B (BAT40...

Embodiment 2

[0356] Example 2. Patterns of somatic mutations in MSH6-deficient hypervariants

[0357] Studies in model organisms and cell lines have revealed that somatic mutations arising due to MMR deficiency involve in most cases affecting microsatellite sequences (dinucleotides with a minimum length of 6 bases and at least two repeat units to Hexanucleotide repeats) and homopolymers (mononucleotide repeats with a minimum length of 6 bases) indels (insertions / deletions) (Ellegren, 2004). To test this hypothesis, we stratified the genome into four distinct categories with the following definitions:

[0358] - Microsatellite region: di-, tri-, tetra-, penta- or hexanucleotide repeats consisting of at least two repeat units and having a minimum length of 6 bases.

[0359] - Homopolymeric regions: mononucleotide repeats with a minimum length of 6 bases.

[0360] - Short homopolymeric regions: mononucleotide repeats of 3, 4 or 5 bases in length.

[0361] - Non-repeated region: every base ...

Embodiment 3

[0371] Example 3. Exome Sequencing of Mismatch Repair Deficient and Competent Tumors and Their Matched Normal Samples

[0372] We selected 10 additional MMR deficient EM and CRC tumors and 4 MMR competent tumors characterized by deficiency of MLH1, MSH2 or MSH6 (Table 9, Table 13). Therefore, a total of 14 tumor-normal pairs were collected for exome sequencing, including 11 endometrial tumors (EM) and their matched germline samples and 3 colorectal tumors (CRC) and their matched germline samples. Yes. All tumors were primary, chemotherapy-naïve tumors. Tumor DNA was derived from fresh-frozen tumor tissue, whereas matched germline DNA for these samples was extracted from peripheral blood leukocytes. Detailed clinical information for all these samples is listed in Table 13. In addition, 5 MMR-deficient primary endometrial tumor cell lines were included in the analysis, bringing a total of 16 MMR-deficient tumor samples.

[0373] Table 13. Clinical Information for Additional ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present application relates to the field of cancer, particularly to mismatch repair (MMR-)deficient tumors. Novel markers are presented herein that have a high sensitivity to detect whether a tumor is mismatch repair deficient or not. The markers are particularly mutations in microsatellite regions. Accordingly, methods are provided for diagnosing microsatellite instability of a tumor, comprising determining the presence of these markers. Further, kits are provided to detect the presence of these markers (or subsets thereof) in a sample.

Description

[0001] This application is a Chinese patent application with an application date of April 10, 2013, and the title of the invention is "a new marker for detection of microsatellite instability in cancer and determination of synthetic lethality associated with DNA base excision repair pathway inhibition" Divisional application of 201380030379.4 (international application number PCT / EP2013 / 057516). technical field [0002] The present application relates to the field of cancer, especially mismatch repair (MMR-) deficient tumors. This article provides new markers with high sensitivity for detecting whether a tumor is mismatch repair deficient. The markers are especially mutations in microsatellite regions. Accordingly, there is provided a method for diagnosing microsatellite instability in a tumor comprising determining the presence of these markers. In addition, kits are provided to detect the presence of these markers (or subsets thereof) in a sample. [0003] Interestingly, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/154C12Q2600/156C12Q2600/106A61P35/00A61P35/02A61P43/00C12Q2600/158C12Q2600/136C12Q2600/112
Inventor D·兰布雷彻特
Owner VLAAMS INTERUNIVERSITAIR INST VOOR BIOTECHNOLOGIE VZW
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap